We are live on ! Find out more
TSS

Two Sigma Securities Portfolio holdings

AUM $861M
1-Year Est. Return 21.33%
This Fund
S&P 500
This Quarter Est. Return
+4.47%
1 Year Est. Return
+21.33%
3 Year Est. Return
+86.85%
5 Year Est. Return
+97.02%
10 Year Est. Return
+293.06%
AUM
$1.09B
AUM Growth
+$570M
Cap. Flow
+$538M
Cap. Flow %
49.18%
Top 10 Hldgs %
26.36%
Holding
1,415
New
578
Increased
168
Reduced
129
Closed
514
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEI
826
DELISTED
Camber Energy, Inc
CEI
0
CIE
827
DELISTED
Cobalt International Energy, Inc
CIE
$21K ﹤0.01%
+14,441
New +$30K
BIOL
828
DELISTED
Biolase, Inc.
BIOL
$20K ﹤0.01%
+3
New +$25.9K
BPTH
829
DELISTED
Bio-Path Holdings Inc
BPTH
$20K ﹤0.01%
+14
New +$19.2K
GEN
830
DELISTED
Genesis Healthcare, Inc.
GEN
$20K ﹤0.01%
+17,235
New +$21.7K
SMRT
831
DELISTED
Stein Mart Inc
SMRT
$20K ﹤0.01%
15,090
+5,023
+50% +$6.52K
ADYX
832
DELISTED
Adynxx Inc
ADYX
$20K ﹤0.01%
+935
New +$19.3K
GIGA
833
DELISTED
Giga-Tronics Inc
GIGA
$19K ﹤0.01%
24,773
+10,785
+77% +$8.06K
RNVA
834
DELISTED
Rennova Health, Inc.
RNVA
$19K ﹤0.01%
6,404
+4,919
+331% +$21K
ARMP icon
835
Armata Pharmaceuticals
ARMP
$167M
$18K ﹤0.01%
+1,430
New +$18.3K
CLRB icon
836
Cellectar Biosciences
CLRB
$20.5M
$18K ﹤0.01%
+3
New +$14.5K
CRDF icon
837
Cardiff Oncology
CRDF
$66.5M
$18K ﹤0.01%
+336
New +$21K
RCON icon
838
Recon Technology
RCON
$39.7M
$18K ﹤0.01%
+186
New +$17.6K
NUWE icon
839
Nuwellis
NUWE
$160K
0
ALIM
840
DELISTED
Alimera Sciences
ALIM
$17K ﹤0.01%
+858
New +$18.4K
ASTC icon
841
Astrotech Corp
ASTC
$13.1M
$16K ﹤0.01%
+110
New +$13.6K
MTNB icon
842
Matinas BioPharma
MTNB
$1.88M
$16K ﹤0.01%
250
-165
-40% -$11K
OTLK icon
843
Outlook Therapeutics
OTLK
$183M
$16K ﹤0.01%
+74
New +$13.5K
REFR icon
844
Research Frontiers
REFR
$14M
$16K ﹤0.01%
+13,800
New +$16.5K
VTNR
845
DELISTED
Vertex Energy, Inc
VTNR
$16K ﹤0.01%
20,658
+10,613
+106% +$9.7K
NBSE
846
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$16K ﹤0.01%
54
+16
+42% +$4.37K
CXRX
847
DELISTED
Concordia International Corp. Common Stock
CXRX
$16K ﹤0.01%
+13,436
New +$18.3K
IPAS
848
DELISTED
Ipass Inc Common Stock
IPAS
$16K ﹤0.01%
2,383
-141
-6% -$1.18K
BIOC
849
DELISTED
Biocept, Inc.
BIOC
$15K ﹤0.01%
+1
New +$11.8K
HLTH
850
DELISTED
Nobilis Health Corp.
HLTH
$15K ﹤0.01%
10,297
-18,297
-64% -$28.9K

Similar funds

Two Sigma Securities's Q3 2017 Portfolio in Review

As of Q3 2017, Two Sigma Securities held 1,415 positions worth $1.09B, up 108% from $525M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Two Sigma Securities deployed $538M of net new capital in Q3 2017, opening 578 new positions and adding to 168 existing holdings. Its largest new stake was Vanguard Consumer Discretionary ETF: 154,706 shares worth $22.2M.

By sector, the portfolio is most concentrated in Financials at 2.3% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR Dow Jones REIT ETF, an estimated $23.5M trimmed.

  • Two Sigma Securities's largest Q3 2017 buy was Vanguard Consumer Discretionary ETF: 154,706 shares worth $22.2M.
  • Two Sigma Securities added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $98.5M increase.
  • Two Sigma Securities's biggest Q3 2017 reduction was State Street SPDR Dow Jones REIT ETF, cutting an estimated $23.5M.
  • Two Sigma Securities fully exited State Street Consumer Staples Select Sector SPDR ETF in Q3 2017, selling an estimated $27M.
  • Two Sigma Securities's ten largest holdings make up 26% of its $1.09B portfolio in Q3 2017.
  • Two Sigma Securities opened 578 new positions and closed 514 in Q3 2017.
  • Two Sigma Securities's portfolio value rose 108% quarter-over-quarter to $1.09B.

Based on Two Sigma Securities's 13F filing for Q3 2017, filed 14 Nov 2017.